[Restless legs syndrome: therapeutic possibilities in the medical practice].
The diagnosis of restless legs syndrome is made on the basis of the clinical symptoms and, if applicable, complemented with a polysomnography. This is followed by neurophysiological examinations and laboratory diagnostics and permits a differentiation between idiopathic and secondary RLS. The therapy depends upon the form and severity of the disease. For secondary RLS, the primary disease must be treated or the symptom-inducing medication must be discontinued. An idiopathic RLS is treated with drugs. Primarily, L-dopa/benserazide and dopaminergic agonists are used, but opioids and anticonvulsants are also successful.
Bachmann
C G
CG
Abteilung Klinische Neurophysiologie, Klinikum der Universität Göttingen.
Trenkwalder
C
C
D018491:Dopamine Agonists / Q000627:therapeutic use; D004568:Electrodiagnosis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007980:Levodopa / Q000627:therapeutic use; D009460:Neurologic Examination; D017286:Polysomnography; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D012148:Restless Legs Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D012307:Risk Factors
D018491:Dopamine Agonists; D007980:Levodopa